BookR: School of Health Core Facilities Booking
PubMed Publications| Keyword search (4,163 papers available) |  |
"Meng X" Authored Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities | Cruz-Santiago D; Meng X; Canac-Marquis M; Sengupta A; Brassard JP; Pavey E; Girouard H; Vinh DC; Gouin JP; | 40051588 PSYCHOLOGY |
| 2 | Infants' Social Evaluation of Helpers and Hinderers: A Large-Scale, Multi-Lab, Coordinated Replication Study | Lucca K; Yuen F; Wang Y; Alessandroni N; Allison O; Alvarez M; Axelsson EL; Baumer J; Baumgartner HA; Bertels J; Bhavsar M; Byers-Heinlein K; Capelier-Mourguy A; Chijiiwa H; Chin CS; Christner N; Cirelli LK; Corbit J; Daum MM; Doan T; Dresel M; Exner A; Fei W; Forbes SH; Franchin L; Frank MC; Geraci A; Giraud M; Gornik ME; Wiesmann CG; Grossmann T; Hadley IM; Havron N; Henderson AME; Matzner EH; Immel BA; Jankiewicz G; Jedryczka W; Kanakogi Y; Kominsky JF; Lew-Williams C; Liberman Z; Liu L; Liu Y; Loeffler MT; Martin A; Mayor J; Meng X; Misiak M; Moreau D; Nencheva ML; Oña LS; Otálora Y; Paulus M; Pepe B; Pickron CB; Powell LJ; Proft M; Quinn AA; Rakoczy H; Reschke PJ; Roth-Hanania R; Rothmaler K; Schlegelmilch K; Schlingloff-Nemecz L; Schmuckler MA; Schuwerk T; Seehagen S; Sen HH; Shainy MR; Silvestri V; Soderstrom M; Sommerville J; Song HJ; Sorokowski P; Stutz SE; Su Y; Taborda-Osorio H; Tan AWM; Tatone D; Taylor-Partridge T; Tsang CKA; Urbanek A; Uzefovsky F; Visser I; Wertz AE; Williams M; Wolsey K; Wong TT; Woodward AM; Wu Y; Zeng Z; Zimmer L; Hamlin JK; | 39600132 PSYCHOLOGY |
| 3 | Prediction of depressive symptoms in young adults by polygenic score and childhood maltreatment: Results from a population-based birth cohort | Scardera S; Geoffroy MC; Langevin R; Perret LC; Collin-Vézina D; Voronin I; Gouin JP; Meng X; Boivin M; Ouellet-Morin I; | 39465601 PSYCHOLOGY |
| Title: | Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities | ||||
| Authors: | Cruz-Santiago D, Meng X, Canac-Marquis M, Sengupta A, Brassard JP, Pavey E, Girouard H, Vinh DC, Gouin JP | ||||
| Link: | https://pubmed.ncbi.nlm.nih.gov/40051588/ | ||||
| DOI: | 10.5770/cgj.28.770 | ||||
| Publication: | Canadian geriatrics journal : CGJ | ||||
| Keywords: | COVID-19; dementia; neuropsychiatric symptoms; nursing homes; older adults; | ||||
| PMID: | 40051588 | Category: | Date Added: | 2025-03-07 | |
| Dept Affiliation: |
PSYCHOLOGY
1 Montreal Geriatrics Institute Research Centre, Montreal. 2 Department of Family and Emergency Medicine, University of Montreal, Montreal. 3 Department of Psychiatry, Faculty of Medicine and Health Sciences, McGill University, Montreal. 4 Douglas Research Center, Montreal. 5 Research Institute of the McGill University Health Centre, Montreal. 6 Department of Pharmacology and Physiology, University of Montreal, Montreal. 7 Infectious Diseases and Immunity in Global Health Program, Montreal. 8 Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal. 9 Department of Psychology, Concordia University, Montreal, QC. |
||||
Description: |
Background: SARS-CoV-2 infection can lead to persistent post-acute neuropsychiatric symptoms. Older adults with multimorbidity may be at increased risk of post-acute symptoms after COVID-19. The goals of the present study were to assess the associations of SARS-CoV-2 infection with neuropsychiatric symptoms and psychotropic medication prescription among older adults living in long-term care facilities. Methods: Nursing home residents (n=111) participated in this three-month longitudinal study. Nurse ratings of neuropsychiatric symptoms were conducted at baseline and at the three-month follow-up. SARS-CoV-2 infection status and psychotropic medication prescription were extracted from a medical chart review. Results: About 73.9% of participants were infected with SARS-CoV-2 on average 480.49 (SD= 228) days before study enrollment. There were no significant changes in neuropsychiatric symptoms during the study follow-up period. Participants with a SARS-CoV-2 infection had more agitation compared to those who were never infected. However, this effect disappeared after adjusting for age, sex, history of psychiatric disorder, neurocognitive status, and multimorbidity. Participants with SARS-CoV-2 had a higher number of psychotropic medication prescription. This effect was driven by increased use of antidepressants and antipsychotic medications. Conclusion: Both acute and short-term neuropsychiatric symptoms associated with COVID-19 may contribute to long-term psychoactive polypharmacy among older adults living in long-term facilities. |
